Statistics
Publications
1
Citations
601
H-Index
1
Active since
2004
Affiliations
Natasha Rozenkrantz is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in drug discovery, thioesterase domains, and cancer pharmacology.
Publications per year
2004–2004
1
1
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Steven J. Kridel, Fumiko Axelrod, Natasha Rozenkrantz et al. · Cancer Research · 2004 · 601 citations · Full text
Medicine, Oncology, Pharmacology +16
1–1 of 1